366 related articles for article (PubMed ID: 15632892)
1. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Schouten O; Poldermans D; Visser L; Kertai MD; Klein J; van Urk H; Simoons ML; van de Ven LL; Vermeulen M; Bax JJ; Lameris TW; Boersma E
Am Heart J; 2004 Dec; 148(6):1047-52. PubMed ID: 15632892
[No Abstract] [Full Text] [Related]
2. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
[TBL] [Abstract][Full Text] [Related]
4. Fluvastatin and perioperative events in patients undergoing vascular surgery.
Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D;
N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772
[TBL] [Abstract][Full Text] [Related]
5. [Beta blockers reduce cardiac complications in patients undergoing surgery].
Hynynen M
Duodecim; 2000; 116(17):1805-7. PubMed ID: 12001633
[No Abstract] [Full Text] [Related]
6. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockade for patients undergoing vascular surgery.
Feldman T; Fusman B; McKinsey JF
N Engl J Med; 2000 Apr; 342(14):1051-2; author reply 1052-3. PubMed ID: 10755896
[No Abstract] [Full Text] [Related]
8. Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation?
Morales JM
Nat Clin Pract Nephrol; 2005 Dec; 1(2):78-9. PubMed ID: 16932372
[No Abstract] [Full Text] [Related]
9. Reducing cardiac risk in noncardiac surgery.
Lee TH
N Engl J Med; 1999 Dec; 341(24):1838-40. PubMed ID: 10588971
[No Abstract] [Full Text] [Related]
10. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
11. Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
Dickerson LM; Carek PJ
J Fam Pract; 2000 Mar; 49(3):203-4. PubMed ID: 10735475
[No Abstract] [Full Text] [Related]
12. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.
Poldermans D; Boersma E; Bax JJ; Thomson IR; van de Ven LL; Blankensteijn JD; Baars HF; Yo TI; Trocino G; Vigna C; Roelandt JR; van Urk H
N Engl J Med; 1999 Dec; 341(24):1789-94. PubMed ID: 10588963
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin plus fish oil are more effective on cardiovascular risk factors than fluvastatin alone.
Singer P
Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):379-80. PubMed ID: 15850720
[No Abstract] [Full Text] [Related]
14. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic beta-blocker use to prevent perioperative morbidity and mortality.
Finley AC; Elliott BM; Robison JJ; Brothers TE
J S C Med Assoc; 2004 Aug; 100(8):223-6. PubMed ID: 15490951
[TBL] [Abstract][Full Text] [Related]
16. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.
Ward RP; Leeper NJ; Kirkpatrick JN; Lang RM; Sorrentino MJ; Williams KA
Int J Cardiol; 2005 Oct; 104(3):264-8. PubMed ID: 16186054
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease.
Lemos PA; de Feyter PJ; Serruys PW; Saia F; Arampatzis CA; Disco C; Mercado N; Mainar V; Morís C; van den Bos AA; Berghoefer G
Int J Cardiol; 2005 Feb; 98(3):479-86. PubMed ID: 15708183
[TBL] [Abstract][Full Text] [Related]
18. Perioperative beta-blocker and statin therapy.
Daumerie G; Fleisher LA
Curr Opin Anaesthesiol; 2008 Feb; 21(1):60-5. PubMed ID: 18195612
[TBL] [Abstract][Full Text] [Related]
19. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery.
Voûte MT; Winkel TA; Poldermans D
Expert Opin Drug Saf; 2010 Sep; 9(5):793-800. PubMed ID: 20557267
[TBL] [Abstract][Full Text] [Related]
20. [Perioperative beta-blockade for reduction of cardiovascular complications in non-cardiac surgery: advantages and disadvantages].
Koelemay MJ; Legemate DA
Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2603-5. PubMed ID: 19102434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]